BD MAX™ ENTERIC PARASITE PANEL
Mexico·Clase I·III. DIAGNOSTIC AGENTS·BECTON DICKINSON DE MÉXICO, S.A. DE C.V.·Registered June 14, 2018PRUEBA DIAGNÓSTICA IN VITRO AUTOMATIZADA PARA LA DETECCIÓN CUALITATIVA DIRECTA DE PATÓGENOS PARASITARIOS INTESTINALES. LA PRUEBA BD MAX ENTERIC PARASITE PANEL DETECTA LOS ÁCIDOS NUCLEICOS DE: • GIARDIA LAMBLIA • CRYPTOSPORIDIUM (C. HOMINIS Y C. PARVU
AUTOMATED IN VITRO DIAGNOSTIC TEST FOR DIRECT QUALITATIVE DETECTION OF INTESTINAL PARASITIC PATHOGENS. THE BD MAX ENTERIC PARASITE PANEL TEST DETECTS NUCLEIC ACIDS FROM: • GIARDIA LAMBLIA • CRYPTOSPORIDIUM (C. HOMINIS AND C. PARVU
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- KIT DE PRUEBA PARA LA DETECCIÓN CUALITATIVA DE PATÓGENOS ENTÉRICOS.
- Trade Name (English)
- TEST KIT FOR THE QUALITATIVE DETECTION OF ENTERIC PATHOGENS.
- Analysis ID
- 1538R2018 SSA
- Registration Date
- June 14, 2018
- Name (Spanish)
- BECTON DICKINSON DE MÉXICO, S.A. DE C.V.
- Name (English)
- BECTON DICKINSON DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for BD MAX™ ENTERIC PARASITE PANEL (BD MAX™ ENTERIC PARASITE PANEL) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1538R2018 SSA and manufactured by BECTON DICKINSON DE MÉXICO, S.A. DE C.V.. The device was registered on June 14, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.